Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small ribosomal subunit protein uS5 (RPS2) is a cytoplasmic protein that forms part of the 40S small subunit of the ribosome, an organelle responsible for catalyzing protein synthesis in eukaryotic cells[1][2][8]. RPS2 is involved in ribosome assembly, translation initiation, and RNA binding, and is crucial for accurate protein translation and cell viability[1][4][8]. It is a member of the S5P family of ribosomal proteins and plays critical roles in nucleolar processing of pre-18S ribosomal RNA and assembly of the functional ribosome[1][2]. Mutations in RPS2 have been linked to Diamond-Blackfan anemia[1]. Additionally, RPS2 can serve as a tumor antigen and may be suitable as a cancer biomarker or immunotherapeutic peptide but is not currently an established therapeutic target[3].
Not applicable (no drugs currently target RPS2 directly for mechanism-of-action studies)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small ribosomal subunit protein uS5 (RPS2).